Pfizer Stock Analysis: Value Trap or Turnaround Opportunity at 8.5x Earnings?
The Market Disconnect: High Yield vs. Growth Skepticism Pharmaceutical giant Pfizer (NYSE: PFE) presents a stark contrast between classic value metrics and modern growth expectations. For dividend-seeking value investors, the stock boasts an attractive 6.8% forward yield—substantially outperforming the S&P 500 average yield of 1.1%. Additionally, PFE trades at a modest valuation of 8.5x forward … Read more




